ZYUS Life Sciences Balance Sheet Health
Financial Health criteria checks 2/6
ZYUS Life Sciences has a total shareholder equity of CA$20.1M and total debt of CA$6.9M, which brings its debt-to-equity ratio to 34.1%. Its total assets and total liabilities are CA$38.2M and CA$18.2M respectively.
Key information
34.1%
Debt to equity ratio
CA$6.85m
Debt
Interest coverage ratio | n/a |
Cash | CA$2.55m |
Equity | CA$20.07m |
Total liabilities | CA$18.15m |
Total assets | CA$38.22m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: ZYUS's short term assets (CA$6.2M) do not cover its short term liabilities (CA$12.8M).
Long Term Liabilities: ZYUS's short term assets (CA$6.2M) exceed its long term liabilities (CA$5.3M).
Debt to Equity History and Analysis
Debt Level: ZYUS's net debt to equity ratio (21.4%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if ZYUS's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ZYUS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ZYUS has less than a year of cash runway if free cash flow continues to grow at historical rates of 19.8% each year.